NDC 71335-3131 – Terazosin

Terazosin Hydrochloride 5 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71335-3131

Product details

Brand name
Terazosin
Generic name
Terazosin
Labeler
Bryant Ranch Prepack
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075667
Marketed since
March 11, 2024
Listing expires
December 31, 2027
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (4)

Package NDCDescriptionSince
71335-3131-1100 CAPSULE in 1 BOTTLE (71335-3131-1)May 21, 2026
71335-3131-230 CAPSULE in 1 BOTTLE (71335-3131-2)May 21, 2026
71335-3131-390 CAPSULE in 1 BOTTLE (71335-3131-3)May 21, 2026
71335-3131-460 CAPSULE in 1 BOTTLE (71335-3131-4)May 21, 2026

Other Terazosin products